Mihail Obrocea is Chief Medical Officer at MAIA Biotechnology, Inc. (MAIA). They have made 1 open-market trade across 1 company since 2022, most recently 2022-08-01.
CIK 0001913265
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MAIA | 27,100 | $30K |
Shares reported on the most recent Form 4, priced at the 2022-08-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MAIA | BUY | 2022-08-01 | 2022-08-02 | $5.00 | $5K | -17.3% | -31.1% | -39.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.